Editorial
The Evolving Landscape of Biologics—Biosimilars, Biobetters, and Bioparallels
Ivo Abraham, PhD; Karen MacDonald, PhD
Original Investigation
Efficacy, Safety, and Tolerability of Oral DFD-29, a Low-Dose Formulation of Minocycline, in Rosacea: Two Phase 3 Randomized Clinical Trials
Neal Bhatia, MD; James Del Rosso, DO; Linda Stein Gold, MD; et al.
Effectiveness of Adalimumab Biosimilars and Originator for Psoriasis
Duc Binh Phan, MSc; Anthony P. Bewley, PhD; Philip Laws, PhD; et al.
Review
Alopecia Areata–Specific Patient-Reported Outcome Measures: A Systematic Review
Emadodin Darchini-Maragheh, MD; Anthony Moussa, MBBS, MS, MSc, MMed; Nicole Yoong, MD; et al.
Earn CME credit
Images in Dermatology
Subungual Amelanotic Melanoma
Xing Fang, MD; Tianjing Gao, MD; Yu Fu, MD
Earn CME credit
JAMA Dermatology Clinicopathological Challenge
Circular Necrotic Yellow-Red Plaque on the Chest
Tian-Yi Zhang, MB; Yue-Ping Zeng, MD
Earn CME credit
Research Letter
Long-Term Efficacy and Safety of Rituximab in Patients With Pemphigus Foliaceus Compared With Pemphigus Vulgaris
Billal Tedbirt, MD; Estelle Houivet, MSc; Maud Maho-Vaillant, PhD; et al.
At-Home LED Devices for the Treatment of Acne Vulgaris: A Systematic Review and Meta-Analysis
Sherry Ershadi, BS; John S. Barbieri, MD, MBA
|